-
1
-
-
17044386953
-
Type 2 diabetes: Principles of pathogenesis and therapy
-
Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333-1346.
-
(2005)
Lancet
, vol.365
, pp. 1333-1346
-
-
Stumvoll, M.1
Goldstein, B.J.2
Van Haeften, T.W.3
-
3
-
-
20644463001
-
Metabolic syndrome and schizophrenia
-
Thakore JH. Metabolic syndrome and schizophrenia. Br J Psychiatry 2005; 186: 455-456.
-
(2005)
Br J Psychiatry
, vol.186
, pp. 455-456
-
-
Thakore, J.H.1
-
4
-
-
18344403045
-
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics
-
Almeras N, Despres JP, Villeneuve J et al. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry 2004; 65: 557-564.
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 557-564
-
-
Almeras, N.1
Despres, J.P.2
Villeneuve, J.3
-
5
-
-
3142769794
-
The effects of antipsychotic therapy on serum lipids: A comprehensive review
-
Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res. 2004; 70: 1-17.
-
(2004)
Schizophr Res
, vol.70
, pp. 1-17
-
-
Meyer, J.M.1
Koro, C.E.2
-
6
-
-
4644354707
-
Atypical antipsychotics and metabolic dysregulation: Evaluating the risk/benefit equation and improving the standard of care
-
Nasrallah HA, Newcomer JW. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J Clin Psychopharmacol 2004; 24 (Suppl 1), S7-14.
-
(2004)
J Clin Psychopharmacol
, vol.24
, Issue.SUPPL. 1
-
-
Nasrallah, H.A.1
Newcomer, J.W.2
-
7
-
-
1842556479
-
Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: Prevalence, monitoring and management
-
Chue P, Kovacs CS. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management. Bipolar Disord 2003; 5 (Suppl 2), 62-79.
-
(2003)
Bipolar Disord
, vol.5
, Issue.SUPPL. 2
, pp. 62-79
-
-
Chue, P.1
Kovacs, C.S.2
-
8
-
-
3342901698
-
Physical health monitoring of patients with schizophrenia
-
Marder SR, Essock SM, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161: 1334-1349.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1334-1349
-
-
Marder, S.R.1
Essock, S.M.2
Miller, A.L.3
-
10
-
-
0141594923
-
Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: Methods, commentary, and summary
-
Kane JM, Leucht S, Carpenter D, Docherty JP. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry 2003; 64(12): 5-19.
-
(2003)
J Clin Psychiatry
, vol.64
, Issue.12
, pp. 5-19
-
-
Kane, J.M.1
Leucht, S.2
Carpenter, D.3
Docherty, J.P.4
-
11
-
-
2942679341
-
"Schizophrenia and diabetes 2003" Expert consensus meeting, Dublin, 3-4 October 2003: Consensus summary
-
Dinan TG and expert group
-
Dinan TG and expert group. "Schizophrenia and diabetes 2003" Expert consensus meeting, Dublin, 3-4 October 2003: consensus summary. Br J Psychiatry 2004; 184(47): s112-s114.
-
(2004)
Br J Psychiatry
, vol.184
, Issue.47
-
-
-
12
-
-
4043157698
-
Testing for diabetes in hospitalised patients prescribed antipsychotic drugs
-
Taylor D, Young C, Esop R et al. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. Br J Psychiatry 2004; 185: 152-156.
-
(2004)
Br J Psychiatry
, vol.185
, pp. 152-156
-
-
Taylor, D.1
Young, C.2
Esop, R.3
-
13
-
-
25844440520
-
Atypical antipsychotic monitoring in the Kilkenny Mental Health Services
-
Feeney L, Mooney M. Atypical antipsychotic monitoring in the Kilkenny Mental Health Services. Ir J Psychol Med 2005; 22: 101-102.
-
(2005)
Ir J Psychol Med
, vol.22
, pp. 101-102
-
-
Feeney, L.1
Mooney, M.2
|